[A14-28] Apixaban (extension of approval) - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Last updated 01.12.2014
Project no.:
A14-28
Commission:
Commission awarded on 25.08.2014 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Heart and circulation
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
Accompanying information| Project no. | Title | Status |
|---|---|---|
| A12-20 | Apixaban - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |
| A11-30 | Apixaban - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |
| G15-01 | Addendum to Commission A14-28 (apixaban) | Commission completed |
Federal Joint Committee (G-BA)
2015-02-19 A G-BA decision was published.